19 July 2021
Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
Researchers from the University of Padua and Imperial College London tested more than 85 percent of the 3,000 residents of Vo’, Italy, in February/March 2020 for infection with SARS-CoV-2, the virus that causes COVID-19, and tested them again in May and November 2020 for antibodies against the virus.
The strength of the immune response does not depend on the symptoms and the severity of the infection Dr Ilaria Dorigatti
The team found that 98.8 percent of people infected in February/March showed detectable levels of antibodies in November, and there was no difference between people who had suffered symptoms of COVID-19 and those that had been symptom-free. The results are published today in
Antibody levels remain high nine months after SARS-CoV-2 infection, study shows
Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
Researchers from the University of Padua and Imperial College London tested more than 85 percent of the 3,000 residents of Vo , Italy, in February/March 2020 for infection with SARS-CoV-2, the virus that causes COVID-19, and tested them again in May and November 2020 for antibodies against the virus.
The team found that 98.8 percent of people infected in February/March showed detectable levels of antibodies in November, and there was no difference between people who had suffered symptoms of COVID-19 and those that had been symptom-free. The results are published today in
19 July 2021
Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
Researchers from the University of Padua and Imperial College London tested more than 85 percent of the 3,000 residents of Vo’, Italy, in February/March 2020 for infection with SARS-CoV-2, the virus that causes COVID-19, and tested them again in May and November 2020 for antibodies against the virus.
The strength of the immune response does not depend on the symptoms and the severity of the infection Dr Ilaria Dorigatti
The team found that 98.8 percent of people infected in February/March showed detectable levels of antibodies in November, and there was no difference between people who had suffered symptoms of COVID-19 and those that had been symptom-free. The results are published today in
COVID-19 antibodies persist at least nine months after infection: Study ANI | Updated: Jul 20, 2021 08:02 IST
London [UK], July 20 (ANI): A new study led by researchers at Imperial College London and University of Padua shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
The results of the study were published in the journal Nature Communications.
Researchers tested more than 85 per cent of the 3,000 residents of Vo , Italy, in February/March 2020 for infection with SARS-CoV-2, the virus that causes COVID-19, and tested them again in May and November 2020 for antibodies against the virus.
The team found that 98.8 per cent of people infected in February/March showed detectable levels of antibodies in November, and there was no difference between people who had suffered symptoms of COVID-19 and those that had been symptom-free.
COVID-19 antibodies persist after nine months
ANI
20 Jul 2021, 12:55 GMT+10
London [UK], July 20 (ANI): A new study led by researchers at Imperial College London and University of Padua shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
The results of the study were published in the journal Nature Communications.
Researchers tested more than 85 per cent of the 3,000 residents of Vo , Italy, in February/March 2020 for infection with SARS-CoV-2, the virus that causes COVID-19, and tested them again in May and November 2020 for antibodies against the virus.
The team found that 98.8 per cent of people infected in February/March showed detectable levels of antibodies in November, and there was no difference between people who had suffered symptoms of COVID-19 and those that had been symptom-free.